This year's articles illustrate how interdisciplinary collaborations are advancing pediatric hematology/oncology and medicine in general. This viewpoint has been central to my own training and approach to research, providing the impetus for assembling these reviews. As an MD/ PhD student in the 1980s, I learned about human diseases and cutting edge basic biology, but these areas intersected relatively infrequently. Twenty years ago, I asked my genetics professor, the late Richard Spielman, why it was necessary to learn the mathematical basis for genetic linkage analysis, which, at the time, we were using to analyze esoteric relationships between blood group antigens and erythrocyte shape. Dr Spielman, who was an outstanding, highly principled scholar, simply rolled his eyes at me. Now, of course, his line of work has changed the face of medicine by providing a means to elucidate the genetic and molecular bases for scores of human diseases. These advances, which were initially difficult to predict, arose from the timely intersection between population genetics and several other fields, including clinical medicine and DNA sequencing technologies.
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As a pediatric intern, I saw patients with Diamond Blackfan anemia (DBA), a puzzling disorder characterized by impaired red cell production and specific developmental anomalies. We had no clue as to what caused this constellation of defects. In the 1990s, several groups used genetic linkage analysis and other methods to map some forms of DBA to a small region of human chromosome 19. In 1999, Dahl and colleagues pinpointed the relevant gene, reporting that approximately 25% of DBA cases are caused by mutations in RPS19, a ubiquitously expressed ribosomal protein. Subsequently, several other ribosomal protein genes were found to be mutated in different cases of DBA. This was surprising, as nobody understood how impaired ribosome function could cause the unique disorders of DBA. Now, investigators are making significant headway. Hematologists interested in understanding and treating DBA are actively collaborating with basic biologists whose studies have focused on basic mechanisms of ribosome structure and function. Suddenly and unpredictably, discoveries linking ribosomal protein genes to a relatively obscure hematologic disease have infused new excitement and significance into previously unrelated disciplines.
Synergistic collaborations between experts from different fields are arguably the most compelling forces behind medical research today. Four different examples, including the story of DBA, are reviewed in this issue of Current Opinions in Pediatrics. Each article describes how pediatric hematologists/oncologists engage in cross-disciplinary interactions to solve current patient problems while advancing basic biologic knowledge that may impact clinical care in far-reaching areas beyond blood and cancer. As new technologies and research discoveries accumulate at a remarkable pace, it is increasingly important to stay tuned for unexpected associations and maintain open lines of communication with our colleagues from disparate areas of science and medicine.
